Indian Immunologicals, Indian Council of Medical Reaearch ink pact for Zika vaccine

The vaccine maker and the national research body have entered into an agreement for the development of the country’s first codon de-optimised live attenuated Zika vaccine, a press release said

Updated - September 13, 2024 03:19 pm IST - HYDERABAD

ICMR D-G Rajiv Bahl and Indian Immunologicals MD K. Anand Kumar at the signing of MoA for clinical development of Zika vaccine.

ICMR D-G Rajiv Bahl and Indian Immunologicals MD K. Anand Kumar at the signing of MoA for clinical development of Zika vaccine.

Vaccine maker Indian Immunologicals (IIL) and Indian Council of Medical Research (ICMR) have signed a memorandum of agreement (MoA) for clinical development of the country’s first codon de-optimised live attenuated Zika vaccine.

ICMR will be funding phase I clinical trial costs, including those relating to the conduct, investigations and monitoring of clinical trial under the agreement. The trial will be conducted at the ICMR network sites in India, IIL said in a release on Thursday.

ICMR’s phase I trial network, launched last year, facilitates first-in-human safety studies for innovative and affordable frontier medtech, including small molecules, biologics and vaccines. With four phase-I sites — ACTREC-Mumbai, KEM Hospital-Mumbai, SRM-Chennai and PGIMER-Chandigarh — fully operational, Indian innovators no longer need to go abroad for phase-I trials, D-G of ICMR Rajiv Bahl said.

IIL has partnered with Griffith University, Australia, to develop the codon de-optimised live attenuated Zika vaccine, which has completed extensive pre-clinical evaluations and received permission from Indian regulatory authority to produce GMP grade materials for clinical developmental work.

The company is working on developing vaccines for several neglected emerging diseases. The list includes Zika, Kyasanur Forest Disease (KFD), Chikungunya and a SARS-CoV-2 intra-nasal booster vaccine, IIL deputy MD Priyabrata Pattnaik said.

A viral infection, Zika is mostly a mosquito-borne disease. Currently there is no vaccine available against Zika, IIL said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.